Select Page

Safe Administration of Oxytocin

As oxytocin is a high alert medication, there is heightened risk of causing significant patient harm when used in error. This report focused on identifying best practice recommendations that can be applied to low risk pregnant patients who are eligible for oxytocin for augmentation or induction of labour. Reducing variation in care and reinforcing safe drug administration principles, helps to reduce adverse outcomes associated with the misuse of oxytocin. To support implementation of these best practices, various tools have been created such as a standardized order set and safety checklist. In report has been formally endorsed by the following organizations:  

Safe Administration of Oxytocin – Download Report

Sample Tools:

For additional information